Isdiben

Isotretinoin, the active ingredient in Isdiben, is a retinoid presented as an oral formulation for oral use. It treats severe nodular acne and refractory acne vulgaris in patients who have not responded to conventional therapies.

GNH USA supplies Isdiben as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isdiben, a retinoid used in dermatology, is indicated for severe forms of acne that are unresponsive to standard treatments. - Severe nodular acne: reduces inflammatory lesions and prevents scarring. - Refractory acne vulgaris: improves skin clearance when other regimens fail. - Severe cystic acne: decreases deep, painful cysts and promotes lesion resolution.

Isotretinoin may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Photosensitivity. - Elevated triglyceride levels. - Headache. - Musculoskeletal pain.

Serious or Rare Side Effects: - Severe depression or suicidal ideation. - Inflammatory bowel disease. - Hepatotoxicity (elevated liver enzymes). - Pseudotumor cerebri (increased intracranial pressure). - Teratogenic effects leading to birth defects. - Severe hypertriglyceridemia.

Before initiating Isdiben therapy, several safety considerations should be observed. - Pregnancy testing: confirm negative test before starting and use effective contraception throughout treatment. - Liver monitoring: assess hepatic function regularly. - Lipid monitoring: check serum triglycerides and cholesterol periodically. - Vitamin A intake: avoid additional vitamin A supplements to prevent toxicity. - Contraception: maintain reliable birth control methods for at least one month after discontinuation. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Isotretinoin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce contraceptive effectiveness. - Systemic corticosteroids: can mask signs of infection. - Antiepileptic drugs (e.g., carbamazepine, phenytoin): may lower isotretinoin plasma levels. - Antifungal azoles: potential increase in isotretinoin concentrations.